Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

According to Bloomberg, the U.S. Supreme Court rescinded the bid filed by The Goldman Sachs Group Inc. (GS - Analyst Report) regarding the dismissal of a lawsuit, accusing it of selling risky debts via misleading statements. The plaintiffs are allowed to pursue the proceedings over their claims against Goldman pertaining to the offering of mortgage-backed securities, underwritten and issued by the bank.

The aforesaid lawsuit has been filed by the institutional investor, NECA-IBEW Health & Welfare Fund. The complaints claimed that Goldman deceptively sold the sub-prime mortgage-linked securities that gradually failed. Moreover, it misrepresented the value of instruments by providing materially misleading statements.

Notably, the fund alleged Goldman of committing forgery in 17 offerings of mortgage-backed certificates. The bank denied the accusations and commented that the fund invested in only two of the 17 offerings, and therefore legal claims can be demanded against those two offerings only.

However, in 2012, N.Y.-based Second U.S. Circuit Court of Appeals permitted NECA to file a lawsuit even against the remaining 15 offerings – in which the fund has not invested. Consequently, NECA came up with this lawsuit.

Among other major banks, Citigroup Inc. (C - Analyst Report), JPMorgan Chase & Co. (JPM - Analyst Report) and Bank of America Corporation (BAC - Analyst Report) have also been legally accused for distorting documents related to mortgage-backed securities and other losses earlier.

The continuously increasing number of lawsuits is sure to dent banks’ reputation and financial conditions. However, investors, who have lost their hard-earned money in such investments, should feel relieved.

Goldman currently retains a Zacks Rank #3 (Hold).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
BITAUTO HOLD BITA 35.33 +14.82%
ANI PHARMACE ANIP 24.79 +14.66%
E HOUSECHINA EJ 10.99 +9.24%
CANADIAN SOL CSIQ 26.97 +7.15%
INTERNATIONA ICAGY 33.30 +5.38%